Role of myocyte enhancing factor 2B in epithelial myofibroblast transition of human gingival keratinocytes

Experimental Biology and Medicine

Volumn 237, Issue 2, 2012, Pages 178-185

  Sun, Qiang ^a,b   Sattayakhom, Apsorn ^a,c   Backs, Johannes ^d   Stremmel, Wolfgang ^a   Chamulitrat, Walee ^a  

^a Forschungsgruppen   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c MAHIDOL UNIVERSITY   (Thailand)

^d Department of Internal Medicine III ^*  (Germany)

Author keywords

Epithelial myofibroblast transition; Immortalized epithelial cells; Myogenic enhancing factor 2; Preneoplastic progression; Tumor invasion

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALDESMON; EPIDERMAL GROWTH FACTOR; FIBRONECTIN; MESSENGER RNA; MYOCYTE ENHANCER FACTOR 2; MYOCYTE ENHANCER FACTOR 2B; PROTEIN E6; PROTEIN E7; UNCLASSIFIED DRUG; VIMENTIN; INTERMEDIATE FILAMENT PROTEIN; MATRIGEL; MYOCYTE ENHANCING FACTOR 2B; MYOSIN HEAVY CHAIN; PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CELL IMMORTALIZATION; CELL INVASION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIAL MYOFIBROBLAST TRANSITION; GINGIVAL KERATINOCYTE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; KERATINOCYTE; MORPHOGENESIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; SPINDLE CELL; UPREGULATION; CELL FRACTIONATION; CELL FUNCTION; CELL TYPE; CELLULAR CONTRACTILITY; CELLULAR TUBULOGENICITY; COBBLESTONE CELL; GENE; METASTASIS; PHENOTYPE; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOFT TISSUE SARCOMA; WESTERN BLOTTING;

CALMODULIN-BINDING PROTEINS; CELL DIFFERENTIATION; DISEASE PROGRESSION; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GINGIVA; HUMANS; KERATINOCYTES; MADS DOMAIN PROTEINS; MYOFIBROBLASTS; MYOGENIC REGULATORY FACTORS; NEOPLASM INVASIVENESS; RNA, MESSENGER; SUBCELLULAR FRACTIONS; VIMENTIN;

EID: 84857339916     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.011261     Document Type: Article

References (40)

1. Petersen OW, Lind Nielsen H, Gudjonsson T, Villadsen R, Rønnov-Jessen L, Bissell MJ. The plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion. Breast Cancer Res 2001;3:213-7
2. Rønnov-Jessen L, Petersen OW, Koteliansky VE, Bissell MJ. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest 1995;95:859-73
3. Zhang Z, Yuan XM, Li LH, Xie FP. Transdifferentiation in neoplastic development and its pathological implication. Histol Histopathol 2001;16:1249-62
4. Masszi A, Speight P, Charbonney E, Lodyga M, Nakano H, Szaszi K, Kapus A. Fate-determining mechanisms in epithelial-myofibroblast transition: major inhibitory role for Smad3. J Cell Biol 2010;188:383-99
5. Weintraub H, Tapscott SJ, Davis RL, Thayer MJ, Lasser AB, Miller AD. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci USA 1989;86:5434-38
6. Boukamp P, Chen J, Gonzales F, Jones PA, Fusenig NE. Progressive stages of 'transdifferentiation' from epidermal to mesenchymal phenotype induced by MyoD1 transfection, 5-aza-2'-deoxycytidine treatment, and selection for reduced cell attachment in the human keratinocyte line HaCaT. J Cell 1992;116:1257-71
7. Huang HY, Antonescu CR. Epithelioid variant of pleomorphic liposarcoma: a comparative immunohistochemical and ultrastructural analysis of six cases with emphasis on overlapping features with epithelial malignancies. Ultrastruct Pathol 2002;26:299-308
8. Nascimento AF, Bertoni F, Fletcher CD. Epithelioid variant of myxofibrosarcoma: expanding the clinicomorphologic spectrum of myxofibrosarcoma in a series of 17 cases. Am J Surg Pathol 2007;31:99-105
9. Lazard D, Sastre X, Frid MG, Glukhova MA, Thiery JP, Koteliansky VE. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci USA 1993;90:999-1003
10. Perez-Montiel MD, Plaza JA, Dominguez-Malagon H, Suster S. Differential expression of smooth muscle myosin, SMA, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue. Am J Dermatopathol 2006;28:105-11
11. Kumar S, Perlman E, Harris CA, Raffeld M, Tsokos M. Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues. Mod Pathol 2000;13:988-93
12. Montgomery E, Speight PM, Fisher C. Myofibromas presenting in the oral cavity: a series of 9 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:343-8
13. Rodini CO, Pontes FS, Pontes HA, Santos PS, Magalhães MG, Pinto DS Jr. Oral leiomyosarcomas: report of two cases with immunohistochemical profile. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104:e50-8
14. Chi AC, Barnes JD, Budnick S, Agresta SV, Neville B. Rhabdomyosarcoma of the maxillary gingiva. J Periodontol 2007;78:1839-45
15. Medjkane S, Perez-Sanchez C, Gaggioli C, Sahai E, Treisman R. Myocardinrelated transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis. Nat Cell Biol 2009;11:257-68
16. Yu YT, Breitbart RE, Smoot LB, Lee Y, Mahdavi V, Nadal-Ginard B. Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes Dev 1992;6:1783-98
17. Edmondson DG, Cheng TC, Cserjesi P, Chakraborty T, Olson EN. Analysis of the myogenin promoter reveals an indirect pathway for positive autoregulation mediated by the muscle-specific enhancer factor MEF-2. Mol Cell Biol 1992;12:3665-77
18. Yamazaki K. Electron microscopy and immunohistochemistry studies of pulmonary carcinosarcomas expressing the transcription factor MEF-2 and showing significant cell-to-cell, cell-to-matrix, and epithelial- mesenchymal interactions. Virchows Arch 2004;444:542-53
19. Yamazaki K. An ultrastructural and immunohistochemical study of elastofibroma: CD 34, MEF-2, prominin 2 (CD133), and factor XIIIa-positive proliferating fibroblastic stromal cells connected by Cx43-type gap junctions. Ultrastruct Pathol 2007;31:209-19
20. Hidaka K, Morisaki T, Byun SH, Hashido K, Toyama K, Mukai T. The MEF2B homologue differentially expressed in mouse embryonal carcinoma cells. Biochem Biophys Res Commun 1995;213:555-60
21. Molkentin JD, Firulli AB, Black BL, Martin JF, Hustad CM, Copeland N, Jenkins N, Lyons G, Olson EN. MEF2B is a potent transactivator expressed in early myogenic lineages. Mol Cell Biol 1996;16:3814-24
22. Morisaki T, Sermsuvitayawong K, Byun SH, Matsuda Y, Hidaka K, Morisaki H, Mukai T. Mouse Mef2b gene: unique member of MEF2 gene family. J Biochem 1997;122:939-46
23. Chamulitrat W, Schmidt R, Chunglok W, Tomakidi P. Epithelium-like and fibroblast-like phenotypes derived from HPV16 E6/E7-immortalized human gingival keratinocytes following chronic ethanol treatment. Eur J Cell Biol 2003;82:313-22
24. Chamulitrat W, Huber A, Riedel HD, Stremmel W. Nox1 induces differentiation resistance in immortalized human keratinocytes generating cells that express simple epithelial keratins. J Invest Dermatol 2007;127:2171-83
25. Dobashi Y, Suzuki S, Sugawara H, Ooi A. Involvement of epidermal growth factor receptor and downstream molecules in bone and soft tissue tumors. Hum Pathol 2007;38:914-25
26. Mayer DCG, Leinwand LA. Sarcomeric gene expression and contractility in myofibroblasts. J Cell Biol 1997;139:1477-84
27. Ngo P, Ramalingam P, Phillips JA, Furuta GT. Collagen gel contraction assay. Methods Mol Biol 2006;341:103-9
28. Sobue K, Hayashi K, Nishida W. Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol Cell Biochem 1999;190:105-18
29. Kordowska J, Huang R, Wang CL. Phosphorylation of caldesmon during smooth muscle contraction and cell migration or proliferation. J Biomed Sci 2006;13:159-72
30. Takeuchi K, Sakurada K, Endou H, Obinata M, Quinlan MP. Differential effects of DNA tumor virus genes on the expression profiles, differentiation, and morphogenetic reprogramming potential of epithelial cells. Virology 2002;300:8-19
31. Chamulitrat W, Sattayakhom A, Herold-Mende C, Stremmel W. Human papillomavirus 16 E6/E7-immortalized human gingival keratinocytes with epithelial mesenchymal transition acquire increased expression of cIAP-1, Bclx and p27(Kip1). Exp Dermatol 2009;18:1067-9
32. Wilkins-Port CE, Higgins PJ. Regulation of extracellular matrix remodeling following transforming growth factor-beta1/epidermal growth factor-stimulated epithelial-mesenchymal transition in human premalignant keratinocytes. Cells Tissues Organs 2007;185:116-22
33. Loeuillet C, Douay L, Hervé P, Chalmers DE. Preservation of the myofibroblastic phenotype of human papilloma virus 16 E6/E7 immortalized human bone marrow cells using the lineage limited alpha-SMA promoter. Cell Growth Differ 2001;12:233-42
34. Frid MG, Shekhonin BV, Koteliansky VE, Glukhova MA. Phenotypic changes of human smooth muscle cells during development: late expression of heavy caldesmon and calponin. Dev Biol 1992;153:185-93
35. D'Addario SF, Morgan M, Talley L, Smoller BR. h-Caldesmon as a specific marker of smooth muscle cell differentiation in some soft tissue tumors of the skin. J Cutan Pathol 2002;29:426-9
36. Yamauchi Y, Kohyama T, Takizawa H, Kamitani S, Desaki M, Takami K, Kawasaki S, Kato J, Nagase T. Tumor necrosis factor-alpha enhances both epithelial-mesenchymal transition and cell contraction induced in A549 human alveolar epithelial cells by transforming growth factor-beta1. Exp Lung Res 2010;36:12-24
37. Akkila WM, Chambers RL, Ornatsky OI, McDermott JC. Molecular cloning of up-regulated cytoskeletal genes from regenerating skeletal muscle: potential role of myocyte enhancer factor 2 proteins in the activation of muscle-regeneration-associated genes. Biochem J 1997;325:87-93
38. Ramachandran B, Yu G, Li S, Zhu B, Gulick T. Myocyte enhancer factor 2A is transcriptionally autoregulated. J Biol Chem 2008;283:10318-29
39. McKinsey TA, Zhang CL, Olson EN. MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem Sci 2002;27:40-7
40. Perrotti V, Rubini C, Fioroni M, Piattelli A. Soft tissue myxoma: report of an unusual case located on the gingiva. J Clin Periodontol 2006;33:76-8